Scout24 SE
SWB:G24
Scout24 SE
SWB:G24
Price:
71.15
EUR
-2.13%
Market Closed
Market Cap:
€5.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Scout24 SE
SWB:G24
|
DE |
|
A
|
Abeona Therapeutics Inc
LSE:0H7R
|
US |
|
D
|
Datagroup SE
XETRA:D6H
|
DE |
|
B
|
Bayzed Health Group Inc
HKEX:2609
|
CN |
Balance Sheet
Balance Sheet Decomposition
Scout24 SE
Scout24 SE
Balance Sheet Decomposition is not available for
Scout24 SE
Scout24 SE
Balance Sheet
Scout24 SE
Scout24 SE
Currency: EUR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
21
|
71
|
43
|
57
|
59
|
66
|
178
|
120
|
39
|
48
|
55
|
|
| Cash |
21
|
71
|
43
|
57
|
59
|
66
|
178
|
120
|
39
|
48
|
55
|
|
| Short-Term Investments |
2
|
0
|
0
|
1
|
2
|
1
|
1 565
|
467
|
0
|
0
|
3
|
|
| Total Receivables |
36
|
38
|
45
|
50
|
65
|
32
|
21
|
25
|
34
|
52
|
52
|
|
| Accounts Receivables |
35
|
38
|
43
|
47
|
59
|
31
|
21
|
23
|
31
|
40
|
37
|
|
| Other Receivables |
0
|
0
|
1
|
3
|
6
|
1
|
0
|
1
|
3
|
12
|
15
|
|
| Other Current Assets |
9
|
9
|
8
|
7
|
10
|
642
|
6
|
8
|
11
|
10
|
8
|
|
| Total Current Assets |
68
|
118
|
96
|
115
|
137
|
740
|
1 769
|
619
|
83
|
111
|
119
|
|
| PP&E Net |
17
|
13
|
10
|
8
|
43
|
31
|
72
|
67
|
60
|
59
|
54
|
|
| PP&E Gross |
17
|
13
|
10
|
8
|
43
|
31
|
72
|
67
|
60
|
59
|
54
|
|
| Accumulated Depreciation |
3
|
9
|
15
|
19
|
31
|
28
|
26
|
36
|
46
|
57
|
66
|
|
| Intangible Assets |
1 277
|
1 243
|
1 201
|
1 173
|
1 169
|
964
|
953
|
940
|
940
|
967
|
974
|
|
| Goodwill |
783
|
787
|
816
|
837
|
1 071
|
693
|
713
|
782
|
785
|
868
|
913
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
6
|
0
|
|
| Long-Term Investments |
42
|
2
|
2
|
2
|
43
|
3
|
13
|
5
|
1
|
5
|
11
|
|
| Other Long-Term Assets |
8
|
10
|
5
|
5
|
1
|
0
|
1
|
0
|
3
|
3
|
1
|
|
| Other Assets |
783
|
787
|
816
|
837
|
1 071
|
693
|
713
|
782
|
785
|
868
|
913
|
|
| Total Assets |
2 195
N/A
|
2 173
-1%
|
2 131
-2%
|
2 140
+0%
|
2 464
+15%
|
2 431
-1%
|
3 520
+45%
|
2 421
-31%
|
1 881
-22%
|
2 019
+7%
|
2 072
+3%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
32
|
26
|
28
|
22
|
38
|
18
|
13
|
17
|
18
|
14
|
18
|
|
| Accrued Liabilities |
20
|
23
|
22
|
25
|
20
|
16
|
12
|
14
|
17
|
25
|
23
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
3
|
4
|
69
|
1
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
6
|
32
|
80
|
28
|
27
|
9
|
67
|
111
|
129
|
138
|
|
| Other Current Liabilities |
36
|
33
|
30
|
32
|
48
|
146
|
39
|
41
|
32
|
43
|
82
|
|
| Total Current Liabilities |
90
|
87
|
112
|
159
|
138
|
211
|
143
|
141
|
178
|
210
|
262
|
|
| Long-Term Debt |
634
|
766
|
642
|
536
|
778
|
821
|
253
|
191
|
51
|
48
|
42
|
|
| Deferred Income Tax |
403
|
393
|
379
|
371
|
357
|
296
|
288
|
281
|
278
|
274
|
269
|
|
| Minority Interest |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
8
|
6
|
8
|
9
|
18
|
49
|
24
|
36
|
25
|
39
|
67
|
|
| Total Liabilities |
1 136
N/A
|
1 253
+10%
|
1 140
-9%
|
1 075
-6%
|
1 292
+20%
|
1 377
+7%
|
707
-49%
|
648
-8%
|
532
-18%
|
572
+8%
|
640
+12%
|
|
| Equity | ||||||||||||
| Common Stock |
2
|
108
|
108
|
108
|
108
|
108
|
106
|
84
|
80
|
75
|
75
|
|
| Retained Earnings |
753
|
389
|
456
|
535
|
641
|
905
|
3 051
|
1 567
|
1 425
|
1 242
|
1 301
|
|
| Additional Paid In Capital |
304
|
424
|
428
|
423
|
424
|
171
|
173
|
195
|
199
|
208
|
208
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
130
|
516
|
72
|
357
|
79
|
153
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
1 059
N/A
|
921
-13%
|
991
+8%
|
1 065
+8%
|
1 173
+10%
|
1 054
-10%
|
2 814
+167%
|
1 774
-37%
|
1 348
-24%
|
1 447
+7%
|
1 432
-1%
|
|
| Total Liabilities & Equity |
2 195
N/A
|
2 173
-1%
|
2 131
-2%
|
2 140
+0%
|
2 464
+15%
|
2 431
-1%
|
3 520
+45%
|
2 421
-31%
|
1 881
-22%
|
2 019
+7%
|
2 072
+3%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
1
|
108
|
108
|
108
|
108
|
105
|
98
|
82
|
74
|
74
|
73
|
|
| Preferred Shares Outstanding |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
